Alto Neuroscience, Inc. Return On Equity in % from 2023 to Q3 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Alto Neuroscience, Inc. quarterly/annual Return On Equity history and growth rate from 2023 to Q3 2025.
  • Alto Neuroscience, Inc. Return On Equity for the quarter ending September 30, 2025 was -47.4 %, a 3.86% increase year-over-year.
  • Alto Neuroscience, Inc. annual Return On Equity for 2024 was -35.6 %, a 157% decline from 2023.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)

Alto Neuroscience, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -47.4 +1.9 +3.86% Jul 1, 2025 Sep 30, 2025
Q2 2025 -44.8 +38.2 +46% Apr 1, 2025 Jun 30, 2025
Q1 2025 -39.8 +2.15K +98.2% Jan 1, 2025 Mar 31, 2025
Q4 2024 -35.6 -98.6 -157% Oct 1, 2024 Dec 31, 2024
Q3 2024 -49.3 Jul 1, 2024 Sep 30, 2024
Q2 2024 -83 Apr 1, 2024 Jun 30, 2024
Q1 2024 -2.19K Jan 1, 2024 Mar 31, 2024
Q4 2023 63 Oct 1, 2023 Dec 31, 2023

Alto Neuroscience, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -35.6 -98.6 -157% Jan 1, 2024 Dec 31, 2024
2023 63 Jan 1, 2023 Dec 31, 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.